Michelet, R.; Ursino, M.; Boulet, S.; Franck, S.; Casilag, F.; Baldry, M.; Rolff, J.; van Dyk, M.; Wicha, S.G.; Sirard, J.-C.;
et al. The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia. Pharmaceutics 2021, 13, 601.
https://doi.org/10.3390/pharmaceutics13050601
AMA Style
Michelet R, Ursino M, Boulet S, Franck S, Casilag F, Baldry M, Rolff J, van Dyk M, Wicha SG, Sirard J-C,
et al. The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia. Pharmaceutics. 2021; 13(5):601.
https://doi.org/10.3390/pharmaceutics13050601
Chicago/Turabian Style
Michelet, Robin, Moreno Ursino, Sandrine Boulet, Sebastian Franck, Fiordiligie Casilag, Mara Baldry, Jens Rolff, Madelé van Dyk, Sebastian G. Wicha, Jean-Claude Sirard,
and et al. 2021. "The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia" Pharmaceutics 13, no. 5: 601.
https://doi.org/10.3390/pharmaceutics13050601
APA Style
Michelet, R., Ursino, M., Boulet, S., Franck, S., Casilag, F., Baldry, M., Rolff, J., van Dyk, M., Wicha, S. G., Sirard, J.-C., Comets, E., Zohar, S., & Kloft, C.
(2021). The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia. Pharmaceutics, 13(5), 601.
https://doi.org/10.3390/pharmaceutics13050601
